he Health Protection Agency is now publishing data on a monthly basis, which is welcomed by MRSA Action UK. The quarterly report was published this week and the overall trend in reduction continues for both MRSA bacteraemias and Clostridium difficile infections. This gives an opportunity for up-to-date analysis and can help patients and GPs make informed choices on where to go for surgery. The data can also be used for benchmarking and management information by Primary Care and Acute Trusts. We have produced regional analyses showing breakdowns by hospital and primary care organisations from the Health Protection Agency data which can be found on the monthly statistics page of our website. The London region has seen a slight increase in MRSA bacteraemias this month and is at the same level as October last year; East of England has also seen a slight increase this month and has also increased on the same period last year. There were a total of 2,496 MRSA bacteraemias recorded over the 13 month period from October 2008 to October 2009. General Medicine, General Surgery, and Geriatric Medicine account for about 65 per cent of MRSA bacteraemias. Nephrology (renal medicine) accounts for the highest rate per 100,000 bed days followed by Clinical Haematology. The highest rates of Clostridium difficile infection are in Critical Care Medicine, Nephrology, Medical Oncology, and Clinical Haematology. Our own analysis of the data has shown that over a period of 13 months, from October 2008 to October 2009 of the 49,261 people who were recorded as having Clostridium difficile, 64 per cent were diagnosed outside of the Acute hospital setting. Whilst there is some debate over previous hospital treatments and the likelihood that a significant proportion may have originally had contact with the bacteria in the hospital environment, this should be regarded as a significant public health risk.